'FDA Approves Reduced Drinking Endpoints for Alcohol Trials: A New Road for Alcohol Treatment?' | @kargerpublishers.bsky.social via @drugwise.bsky.social karger.com/ear/article/...
Reduction in drinking (not only abstinence) has been included as a secondary outcome measure in most clinical trials for alcohol use disorder (AUD). Still reduction in drinking was never a formally ap...